Incruse Ellipta
umeclidinium
- Strength
- 62.5 ug/1
- Form
- Aerosol, Powder
- Class
- Anticholinergic
GlaxoSmithKline LLC
Not stocked by us — reference only
umeclidinium bromide and vilanterol trifenatate
Listed by GlaxoSmithKline LLC
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Powder |
|---|---|
| Route | Respiratory (inhalation) |
| Drug class | Anticholinergic; beta2-Adrenergic Agonist |
| Approval route | NDA — original brand approval |
| NDC code | 0173-0869 |
| FDA application | NDA203975 |
| RxNorm concept | 1487519 |
| Package sizes listed | 2 |
| Marketed since | January 2014 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
umeclidinium
GlaxoSmithKline LLC
Not stocked by us — reference only
umeclidinium bromide and vilanterol trifenatate
Prasco Laboratories
Not stocked by us — reference only
umeclidinium
Prasco Laboratories
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.